期刊文献+

TRAIL系统与肿瘤细胞的凋亡 被引量:2

TRAIL System and Apoptosis of Tumor Cells
暂未订购
导出
摘要 目的了解TRAIL及其受体的结构功能、凋亡途径及在临床肿瘤治疗中的应用前景。方法参阅国内外文献,就有关的研究资料做一综述。结果研究资料表明TRAIL是肿瘤坏死因子家族的新成员,能选择性诱导肿瘤细胞凋亡,而对大多数正常细胞无毒性作用,且与传统的放疗、化疗有协同作用,有可能成为一种新型抗肿瘤药物。结论TRAIL能诱导肿瘤细胞凋亡,在临床肿瘤治疗中有良好的应用前景。
作者 沈滟 赵大治
出处 《河南科技大学学报(医学版)》 2006年第4期318-320,共3页 Journal of Henan University of Science & Technology:Medical Science
  • 相关文献

参考文献4

二级参考文献20

  • 1PanG Orourke K Chinnaiyan AM et al.The receptor for cytotoxic ligand TRAIL[J].Science,1997,276(5309):111-113.
  • 2Wiley SR, Schooley K, Smolak D, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995,3:673 - 682.
  • 3Pitti RM, Marsters SA, Ruppert, et al. Induction of apoptosis by Apo-2 ligand, a new member of the Tumor Necrosis Factor cytokine family. J Biol Chem, 1996,271(22):12687 - 12690.
  • 4Liu Yanxin, Zhu Xun, Ma Zhengyu, et al. Expression, purification of and biological activity of rsTRAIL in E. Coli. Chin Sci Bulletin, 1999,Vol 44(14) : 1306 - 1309.
  • 5Hymowitz SG, O' Connel MP, Uhsch MH, et al. A Uhique zincbinding site revealed by high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry, 2000,39: 633 - 640.
  • 6Wiley S R, Schooley K, Smolak P J, Din W S, Huang C P, Nicholl J K, Sutherland G R, Davis T D, Smith C, Rauch C, Smith C A,Goodwin R G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995, 3(4) :673
  • 7Pitti R M , Marsters S A, Ruppert S, Donahue C J, Moore A,Ashkenazi A. Induction of apoptosis by Apo-2 ligand , a new member of the tumor necrosis factor cytokine family. J Biol Chem, 1996, 271(22): 12687 - 12690
  • 8Pan G H,O' Rourke K , Chinnaiyan A M, Gentz R, Ebner R, Ni J,Dixit V M. The receptor for cytotoxic ligind TRAIL. Science, 1997,276(5306) :lll- 113
  • 9MacFarlane M, Ahmad M, Srinivasula S M, FemandesAlnemri T,Cohen G M, Alnemri E S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem, 1997,272(41) :25417 ~ 25420
  • 10Degli-Esposti M A, Smolak P J, Walczak H, Waugh J, Huang C P,DuBose R F, Smith C A, Goodwin R G. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med, 1997, 186(7): 1165 ~ 1170

共引文献28

同被引文献35

  • 1唐艳旻,张丽梅,杨世方,朱冰,崔俊生,贾慧.重组变构人TRAIL对非小细胞肺癌细胞的体外抑制作用[J].基础医学与临床,2005,25(6):512-516. 被引量:3
  • 2张梅春,胡成平,陈琼,杨红忠.rhTRAIL对耐顺铂人肺腺癌细胞凋亡的影响[J].中国肺癌杂志,2005,8(5):419-423. 被引量:4
  • 3施敏骅,余勇,钱斌,连一新,陈锐,杜紫燕,胡华成.TRAIL和抗肿瘤药物协同诱导非小细胞肺癌凋亡的实验研究[J].苏州大学学报(医学版),2006,26(2):190-192. 被引量:5
  • 4冯长根,周汉生,唐艳平,沈滟.rsTRAIL诱导人肺癌细胞系A549的细胞凋亡表达谱变化研究[J].中国药学杂志,2006,41(9):675-678. 被引量:4
  • 5Wiley SR, Schooley K, Smolak PJ. Identification and characterization of a new member of the TNF family that induees apoptosis. Immunity, 1995, 3(6): 673- 682.
  • 6Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science, 1997,276(5309): 111-113.
  • 7Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science, 1997, 277(5327): 815-818.
  • 8Marsters SA, Sheridan JP, Pitti RM, et al. A novel receptor for Apo2L/ TRAIL contains a truncated death domain. Curr Biol, 1997, 7(12): 1003-1006.
  • 9Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem, 1998, 273(23): 14363-14367.
  • 10Trabzuni D, Famulski KS, Ahmad M. Functional analysis of tumor necrosis factor-ct-related apoptosis-inducing ligand (TRAIL): cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine. Biol Chem, 2000, 350(2): 505-510.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部